{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-054839","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2025-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.557506+00:00","generated_at":"2026-05-19T06:23:02.169368+00:00","sec_items":["5.08","8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Adial Pharmaceuticals postpones 2025 Annual Meeting to August 1, 2025","bullets":["Annual Meeting date moved from prior schedule to August 1, 2025; record date remains June 4, 2025.","Stockholders planning to solicit proxies for non-management director nominees must provide Rule 14a-19 notice by June 26, 2025.","Meeting time and location to be detailed in amended definitive proxy statement to be filed with the SEC."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-054839","json":"https://secwatch.observer/filing/0001213900-25-054839.json","markdown":"https://secwatch.observer/filing/0001213900-25-054839.md","text":"https://secwatch.observer/filing/0001213900-25-054839.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025054839/0001213900-25-054839-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025054839/ea0245887-8k_adial.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T06:23:02.169368+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}